Biostate AI
PrivateLast Round
Series A
May 20, 2025
Total Funding Raised
$16M
Company Overview
Biostate AI is a biotechnology company that provides a platform for RNA sequencing and develops generative artificial intelligence models to predict disease and drug response.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biostate AI Comparables
Compare Biostate AI with similar companies based on industry and business-model similarity.
Biostate AI Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 20, 2025 | ||||
| Seed | Jul 9, 2024 |
Biostate AI Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Yuanjing Capital | Seed, Series A |
| Gaingels | Series A |
| Catapult VC | Seed |
| California Institute of Technology Investment Office | Seed |
| Matter Venture Partners | Series A, Seed |
| Catapult Ventures | Series A |
| Info Edge Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 29, 2025
Partnered with Narayana Health to predict cardiovascular disease.
- Jul 25, 2025
Developing AI models for melanoma immunotherapy with Mass General Brigham.
Biostate AI Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Biostate AI's valuation, stock price, and market status.
Is Biostate AI a public or private company?
Biostate AI is a private company.
What is the current stock price of Biostate AI?
Biostate AI is a private company, so its shares have no public market price. Caplight tracks Biostate AI's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Biostate AI worth (valuation)?
Valuation information for Biostate AI is not publicly available.
Can I buy Biostate AI stock?
Biostate AI shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Biostate AI's last funding round?
Biostate AI's most recent funding round was Series A on May 20, 2025.
Who are the main investors in Biostate AI?
Key investors in Biostate AI include Matter Venture Partners, Accel.
Will Biostate AI IPO soon?
No public IPO plans have been announced for Biostate AI.
How can I track Biostate AI secondary market activity?
Caplight tracks bids, offers, and trades in Biostate AI's shares on secondary markets.